O-04: INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB IN A REAL-WORLD SETTING: RESULTS FROM A MANAGED ACCESS PROGRAM (MAP)

Detalles Bibliográficos
Autores principales: A., SILVA-PINTO, R., COLOMBATTI, A., PASANISI, F., ARCIONI, L., DEBONNETT, W., SOLIMAN, R., SARKAR, R., CANÇADO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426842/
http://dx.doi.org/10.1097/01.HS9.0000872824.25632.d4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426842/
http://dx.doi.org/10.1097/01.HS9.0000872824.25632.d4

Ejemplares similares